Kai Xu

Kai Xu

National Institutes of Health - Bethesda / United States
Others
AD Scientific Index ID: 4399186
person_outline Kai Xu's MOST POPULAR ARTICLES
1-) Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivityM Hervé, K Xu, YS Ng, H Wardemann, E Albesiano, BT Messmer, ...The Journal of clinical investigation 115 (6), 1636-1643, 20054042005
2-) Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibodyR Kong, K Xu, T Zhou, P Acharya, T Lemmin, K Liu, G Ozorowski, C Soto, ...Science 352 (6287), 828-833, 20162952016
3-) Architecture of Eph receptor clustersJP Himanen, L Yermekbayeva, PW Janes, JR Walker, K Xu, L Atapattu, ...Proceedings of the National Academy of Sciences 107 (24), 10860-10865, 20102932010
4-) Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1K Xu, P Acharya, R Kong, C Cheng, GY Chuang, K Liu, MK Louder, ...Nature medicine 24 (6), 857-867, 20183012018
5-) Enhanced neutralization resistance of SARS-CoV-2 omicron subvariants BQ. 1, BQ. 1.1, BA. 4.6, BF. 7, and BA. 2.75. 2P Qu, JP Evans, JN Faraone, YM Zheng, C Carlin, M Anghelina, ...Cell host & microbe 31 (1), 9-17. e3, 20232312023